Search

Novel Treatment: Upgrading the Standard of Care for Neuromyelitis Optica Spectrum Disorder (NMOSD)

RELEASE DATE: November 18, 2021 EXPIRATION DATE: November 18, 2022 FACULTY Dean Wingerchuk, MD, MSc, FRCP(C) Professor and Chair Department of Neurology Mayo Clinic Phoenix/Scottsdale, Arizona Claudia Lucchinetti, MD Chair, Department of Neurology Dean, Clinical and Translational Science Mayo Clinic Rochester, Minnesota PROGRAM OVERVIEW This enduring activity will cover the treatment of patients with neuromyelitis optica spectrum …

Science and Self: Monitoring Response to MS Treatment with Biomarkers and Patient Reported Outcomes

Live Webinar Wednesday, December 1, 2021 7:00 – 8:00 pm EST This timely live webinar will provide an overview of the efficacy, safety, side effects, and immune system impact of MS disease-modifying therapies. With featured speaker: Edward J. Fox, MD, PhD Director, MS Clinic of Central Texas Central Texas Neurology Consultants Clinical Associate Professor, University …

1,800 Seconds™ in Vaccines and MS Treatment

Release Date: October 7, 2021 Valid for Credit Through: October 7, 2022 This activity is jointly provided by The Consortium of Multiple Sclerosis Centers (CMSC) and Catamount Medical Education. Supported by an independent educational grant from Biogen. Credit Available Physicians— maximum of 0.5 AMA PRA Category 1 Credit(s)™ Nurses— maximum of 0.5 contact hours of nursing continuing professional …

IJMSC: Evaluation of Treatment Practices for Urinalyses and Urine Cultures at an Outpatient Multiple Sclerosis Clinic

Release Date: October 1, 2021 Valid for Credit Through: October 1, 2022 Evaluation of Treatment Practices for Urinalyses and Urine Cultures at an Outpatient Multiple Sclerosis Clinic Nicole C. Griffith, PharmD; Brandon K. Hill, PharmD; Myla D. Goldman, MD; S. Ross Tingen, PharmD Target Audience: The target audience for this activity is physicians, physician assistants, …

Medical Minute: Influence of Sleep Disturbances and Obesity on MS and Associated Symptoms

Physicians: maximum of 0.5 AMA PRA Category 1 Credits™ Registered Nurses: 0.5 Nursing contact hours Released: August 27, 2021 Expiration: August 26, 2022 Learning Objectives Upon completion of this activity, participants should be able to: Adopt best practices in recognizing and managing comorbidities in patients with MS Discuss the influence of comorbidities on MS treatment …

Medical Minute: Influence of Anxiety and Depression on MS and Associated Symptoms

Physicians: maximum of 0.5 AMA PRA Category 1 Credits™ Registered Nurses: 0.5 Nursing contact hours Released: August 26, 2021 Expiration: August 25, 2022 Learning Objectives Upon completion of this activity, participants should be able to: Adopt best practices in recognizing and managing comorbidities in patients with MS Discuss the influence of comorbidities on MS treatment …

The Importance of Managing Fatigue in Multiple Sclerosis

Physicians: maximum of 0.25 AMA PRA Category 1 Credits™ Registered Nurses: 0.25 Nursing contact hours Released: August 26, 2021 Expiration: August 25, 2022 Learning Objectives Upon completion of this activity, participants should be able to: Adopt best practices in recognizing and managing comorbidities in patients with MS Target Audience This program is intended for neurologists, …

Managing MS: A Team Approach – Broadcast Series

Patients with multiple sclerosis require care from a comprehensive network of providers, from neurologists to physical therapists, psychiatrists, and speech therapists. Join Patricia Bobryk, MHS, PT, MSCS, ATP, for a weekly broadcast series, where she speaks with experts in these fields to gain insight on and review the clinical issues faced by patients with MS. …

5-Part Podcast Series: Recent Clinical Updates in the Management of Multiple Sclerosis

Earn 1.25 AMA PRA Category 1 Credit(s)™, 1.25 contact hours for nursing professionals, 1.25 contact hours (.1 CEUs) for pharmacists, or 1.25 AAPA Category 1 CME credits The rapidly expanding range of disease modifying therapies (DMTs) has changed the clinical approach to the management of patients with multiple sclerosis (MS). The emergence of numerous therapeutic options …